Last reviewed · How we verify
Cluster headache syndrome
Approved treatments
- Norgesic · Hikma
- Ergot · Samuel Lunenfeld Research Institute, Mount Sinai Hospital
- phenobarbitone · Institute of Child Health
- Migranal · Bausch Health
- Imitrex · GSK
Imitrex works by binding to serotonin receptors in the brain, specifically the 5-HT1D subtype, to constrict blood vessels and block pain pathways. - Migergot
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Cluster headache syndrome patent landscape — cliff calendar, originator estates, attackable patents
- Cluster headache syndrome treatment landscape brief
- Cluster headache syndrome treatment updates RSS
Frequently asked questions about Cluster headache syndrome
What drugs treat Cluster headache syndrome?
Tracked treatments include Norgesic, Ergot, phenobarbitone, Migranal, Imitrex, Migergot.
What is the treatment for Cluster headache syndrome?
Standard treatment for Cluster headache syndrome includes Norgesic, Ergot, phenobarbitone, Migranal, Imitrex. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Cluster headache syndrome patent cliff · Cluster headache syndrome CI report
- Treatment: Norgesic · Hikma
- Treatment: Ergot · Samuel Lunenfeld Research Institute, Mount Sinai Hospital
- Treatment: phenobarbitone · Institute of Child Health
- Treatment: Migranal · Bausch Health
- Treatment: Imitrex · GSK
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing